Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
Annals of Surgery
|
December 19, 2019
The Prevalence and Significance of Jejunal and Duodenal Bulb Polyposis After Duodenectomy in Familial Adenomatous Polyposis: Retrospective Cohort Study
Ji Yoon Yoon, Neal Mehta, Carol A Burke, et al.
Familial Cancer
|
April 6, 2021
Malignancy risk in individuals with familial adenomatous polyposis receiving biologics and immunomodulators
Muhammad Salman Faisal, Carol A Burke, Jean-Paul Achkar, et al.
Gastrointestinal Endoscopy
|
July 12, 2021
Clinically actionable findings on surveillance EGD in asymptomatic patients with Lynch syndrome
Natalie Farha, Jennifer Hrabe, Joseph Sleiman, et al.
World Journal of Clinical Oncology
|
February 4, 2022
Association of cancer with comorbid inflammatory conditions and treatment in patients with Lynch syndrome
Muhammad S Faisal, Carol A Burke, David Liska, et al.
Familial Cancer
|
June 9, 2020
Chemoprevention in familial adenomatous polyposis: past, present and future
Phillip M Kemp Bohan, Gautam Mankaney, Timothy J Vreeland, et al.
Diseases of the Colon and Rectum
|
December 9, 2021
Evaluation of Urinalysis-Based Screening for Urothelial Carcinoma in Patients With Lynch Syndrome
Hanumant Chouhan, Mohammad Ali Abbass, Jennifer E Hrabe, et al.
Gut
|
May 31, 2022
Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis
N Jewel Samadder, Nathan Foster, Ryan P McMurray, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
Annals of Surgery
|
December 19, 2019
The Prevalence and Significance of Jejunal and Duodenal Bulb Polyposis After Duodenectomy in Familial Adenomatous Polyposis: Retrospective Cohort Study
Ji Yoon Yoon, Neal Mehta, Carol A Burke, et al.
Familial Cancer
|
April 6, 2021
Malignancy risk in individuals with familial adenomatous polyposis receiving biologics and immunomodulators
Muhammad Salman Faisal, Carol A Burke, Jean-Paul Achkar, et al.
Gastrointestinal Endoscopy
|
July 12, 2021
Clinically actionable findings on surveillance EGD in asymptomatic patients with Lynch syndrome
Natalie Farha, Jennifer Hrabe, Joseph Sleiman, et al.
World Journal of Clinical Oncology
|
February 4, 2022
Association of cancer with comorbid inflammatory conditions and treatment in patients with Lynch syndrome
Muhammad S Faisal, Carol A Burke, David Liska, et al.
Familial Cancer
|
June 9, 2020
Chemoprevention in familial adenomatous polyposis: past, present and future
Phillip M Kemp Bohan, Gautam Mankaney, Timothy J Vreeland, et al.
Diseases of the Colon and Rectum
|
December 9, 2021
Evaluation of Urinalysis-Based Screening for Urothelial Carcinoma in Patients With Lynch Syndrome
Hanumant Chouhan, Mohammad Ali Abbass, Jennifer E Hrabe, et al.
Gut
|
May 31, 2022
Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis
N Jewel Samadder, Nathan Foster, Ryan P McMurray, et al.
Page
of 4